Skip to content

Depression: all studies

Page 743 of 1,042: studies 7,421 to 7,430 of 10,414, newest first. Back to the depression overview

Research

Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice

Pharmacology, Biochemistry, and Behavior December 5, 2022 Youge Qu, Lijia Chang, Li Ma et al. 42 citations

Classical psychedelics with 5-hydroxytryptamine-2A receptor (5-HT2AR) agonism have rapid antidepressant actions in patients with depression. However, there is an ongoing debate over the role of 5-HT2AR in the antidepressant-like actions of psychedelics. In this study, we compared the effects of DOI (2,5-dimethoxy-4-iodoamphetamine: a hallucinogenic psychedelic drug with potent 5-HT2AR agonism),...

The economics of psychedelic-assisted therapies: A research agenda

Frontiers in Psychiatry December 5, 2022 Elliot Marseille, Stefano Bertozzi, James G. Kahn 51 citations

After a long hiatus, psychiatry is undergoing a resurgence of interest in psychedelic drugs as therapy for a wide range of mental health disorders Accumulating clinical evidence suggests substantial potential for psychedelics used in a therapeutic context, as treatment for, among other disorders, depression, post-traumatic stress disorder (PTSD), and addictions to tobacco, opioids and alcohol....

DOI: 10.3389/fpsyt.2022.1025726 (opens in new tab) MDMA Psilocybin Cost-effectiveness Health economics +5

Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice

International Journal of Molecular Sciences December 4, 2022 Mireia Medrano, An Buckinx, Ilse Smolders et al. 11 citations

Serotoninergic psychedelics such as psilocybin have been reported to elicit a long-lasting reduction in depressive symptoms. Although the main target for serotoninergic psychedelics, serotonin type 2A receptor (5-HT2A), has been established, the possible mechanism of the antidepressant action of psychedelics remains unknown. Using the mouse forced swim test model, we examined whether the...

Mindfulness based intervention through mobile app for colorectal cancer people awaiting surgery: A randomized clinical trial.

Cirugia espanola December 2022 Cristina Rocamora González, Beatriz Rodriguez-Vega, Marta Torrijos Zarcero et al.

Colorectal cancer is the third most common cancer worldwide both in men and women. Around one-third of patients with cancer will suffer from anxiety or depression symptoms. The aim of this study was to evaluate the effectiveness of a Mindfulness-based stress reduction intervention through a mobile application ("En Calma en el Quirófano"). This study is a multicenter, single-blind (evaluator),...

DOI: 10.1016/j.cireng.2022.08.008 (opens in new tab) Full text (opens in new tab) Mindfulness Colorectal cancer Cáncer colorrectal New technologies +3

Review of I. Z. Khazan (2019), Biofeedback and Mindfulness in Everyday Life: Practical Solutions for Improving Your Health and Performance. W. W. Norton and Company.

Applied Psychophysiology and Biofeedback December 2022 Fred Bruce Shaffer, Donald Moss

Dr. Inna Khazan is the preeminent authority on integrating biofeedback with mindfulness. She wrote Biofeedback and Mindfulness in Everyday Life for biofeedback clients, individuals seeking self-improvement, clinicians, performance coaches, and students. Part I, Physiological Principles, describes the major biofeedback modalities, breathing physiology, and heart rate variability. Part II,...

Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review.

Archives of Physical Medicine and Rehabilitation December 2022 Radha Korupolu, Aila Malik, Chelsea G Ratcliff et al.

This systematic review aims to gain a comprehensive understanding of the feasibility, acceptability, and efficacy of mindfulness-based interventions (MBIs) on depression, anxiety, fatigue, and health-related quality of life among individuals with upper motor neuron disorders (UMNDs). PubMed, PsycINFO, Excerpta Medica Database, and Cumulative Index to Nursing and Allied Health Literature were...

Co-Occurring Subacute Combined Degeneration and Guillain-Barré Syndrome Resulting From Nitrous Oxide Abuse: A Case Report.

Cureus December 1, 2022 Kristen Strom, Ateaya Lima, Vahideh Tabarzadi

Growing in prevalence as a recreational drug of abuse across a broad scope of people, nitrous oxide (N2O) has proven to be a public health concern. Side effects of its abuse have a great degree of variation among people ranging from neurologic, psychiatric, and medical symptoms. We present a rare case of a 23-year-old female with a history of N2O abuse, who presented with symptoms of both...

Two Cases of Severe Amanita Muscaria Poisoning Including a Fatality.

Wilderness and Environmental Medicine December 1, 2022 Ethan M Meisel, Brent Morgan, Michael A Schwartz et al.

Ingestion of Amanita muscaria mushrooms results in transient central nervous system excitation and depression mediated by its components, ibotenic acid and muscimol. The mushroom is distributed worldwide and ingestions occur with some frequency. Although these ingestions have traditionally been considered benign, serious complications can occur. We present 2 cases of serious toxicity, including...

Yoga and the Need of Its Integration in Modern Medicine

Journal of the Association of Physicians of India December 1, 2022 Gouranga Santra 18 citations

INTRODUCTION: Growing evidences of the health benefits of yoga are available in the literature. But physicians are not aware of it. METHODOLOGY: Databases like PubMed, PubMed Central, Google Scholar, and Scopus are searched for the articles on preventive, therapeutic, and rehabilitation potential of yoga. Scientific evidences available are analyzed and incorporated into the article. RESULT:...

DOI: 10.5005/japi-11001-0142 (opens in new tab) Anxiety Mindfulness Allostatic load Integrative medicine +9

Psilocybin-Assisted Psychotherapy in Palliative Care

Oxford University Press eBooks December 1, 2022 Stephen Ross, Anthony P. Bossis

Abstract Following a decades-long hiatus and building on an innovative research model first developed from the 1960s to 1970s utilizing psychedelic therapeutics to alleviate the marked psychic distress in end-of-life cancer patients, major academic centers are resuming contemporary clinical research into the safety and efficacy of psilocybin and other serotonergic psychedelics delivered in...

DOI: 10.1093/med/9780197583838.003.0042 (opens in new tab) Psilocybin Psychotherapist Palliative care Distress +2